Nanoparticles shed by cancer cells into the bloodstream could become a new tool for making more precise diagnoses and tailoring the treatment of people with brain cancer. The method could identify tumours more accurately in a minimally invasive way while also enabling doctors to monitor how the disease develops over time, says a researcher.
